Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (4): 294-299.doi: 10.35541/cjd.20200764

• Melanoma·Original Articles • Previous Articles     Next Articles

Signal crosstalk of VEGF-IL-6-STAT3 between cutaneous melanoma cells and vascular endothe-lial cells

Yang Jingyu1, Gu Jiarong2,3, Guo Jing1, Yang Rui1, Wang Wencheng1, Li Yunfeng1, Xu Ping1, Gu Jinhai2   

  1. 1Department of Dermatology, People′s Hospital of Ningxia Hui Autonomous Region, Yinchuan 750021, China; 2Key Laboratory of Craniocerebral Diseases, Ningxia Medical University, Yinchuan 750004, China; 3Department of Preventive Medicine, School of Medicine, Ningbo University, Ningbo 315211, Zhejiang, China
  • Received:2020-07-31 Revised:2021-01-23 Online:2021-04-15 Published:2021-03-31
  • Contact: Gu Jinhai E-mail:gjinhai@126.com
  • Supported by:
    National Natural Science Foundation of China (81160312); Ningxia Natural Science Foundation (2018AAC03268)

Abstract: 【Abstract】 Objective To investigate mechanisms underlying the signal crosstalk of VEGF-IL-6-STAT3 between cutaneous melanoma cells and vascular endothelial cells. Methods EC-304 vascular endothelial cells were divided into 3 groups: control group cultured in conventional endothelial cell-conditioned medium, vascular endothelial growth factor (VEGF) group cultured in endothelial cell-conditioned medium containing 50 μg/L VEGF165, A375 co-culture group co-cultured with a melanoma cell line A375. After 24-, 48- and 72-hour treatment, the culture medium was collected, and enzyme-linked immunosorbent assay was performed to detect the level of interleukin-6 (IL-6). Cultured A375 cells were divided into 4 groups: control group receiving conventional culture in Dulbecco′s modified Eagle′s medium (DMEM), A375 + EC-304 group co-cultured with EC-304 cells, A375 + EC-304 + IL-6 group co-cultured with EC-304 cells in DMEM containing 50 μg/L IL-6 (an agonist of the signal transducer and activator of transcription-3 [STAT3] pathway ), A375 + EC-304 + JSI-124 group co-cultured with EC-304 cells in DMEM containing 1 μmol/L JSI-124(a STAT3 pathway inhibitor). After 24-, 48- and 72-hour treatment, cells were collected, and Western blot analysis, cell counting kit-8 (CCK8) assay and Transwell invasion assay were performed to determine the protein expression of STAT3 and phosphorylated (p)-STAT3, cellular proliferative activity and invasive activity, respectively. Two-way analysis of variance and t test were used for statistical analysis. Results The level of IL-6 significantly increased in the culture medium of EC-304 cells in the VEGF group and A375 co-culture group compared with the control group (FVEGF = 29.63, P < 0.001; FA375 = 11.09, P = 0.020). Compared with the control group, the A375 + EC-304 group showed significantly enhanced protein expression of p-STAT3 in A375 cells (P < 0.001), increased cell activity (P < 0.001), and increased number of invasive cells (152.66 ± 16.04 vs. 86.13 ± 7.24, t = 4.43, P < 0.001); compared with the A375 + EC-304 group, the A375 + EC-304 + IL-6 group showed significantly increased protein expression of p-STAT3 (P < 0.001), enhanced cell activity (P < 0.001), and increased number of invasive cells (187.34 ± 14.38, t = 2.17, P < 0.001); compared with the A375 + EC-304 group, the A375 + EC-304 + JSI-124 group showed significantly decreased protein expression of p-STAT3 (P < 0.001), decreased cell activity (P < 0.001), and decreased number of invasive cells (124.92 ± 8.72, t = -1.86, P < 0.001). Conclusion There is a signal crosstalk of VEGF-IL-6-STAT3 between cutaneous melanoma cells and vascular endothelial cells, which may play an important role in the proliferation and invasion of A375 cells.

Key words: Cutaneous malignant melanom, Vascular endothelial cell, VEGF, IL-6, STAT3, Crosstalk